Three global dividend plays for clients’ portfolios
What’s in a name? Exploring the EM acronyms
Missing out: Are investors paying too much for certainty?
UK equity income funds recorded their best month on record in April as the ongoing demand for income solutions saw them rake in hundreds of millions of pounds.
PA Portfolio: Are frontier markets a viable alternative to underperforming EMs?
European equities have been going full steam ahead so far this year, but has the ship sailed for slow to react investors?
Hargreaves Lansdown has secured what it says is the cheapest share class in the market for Neil Woodford's new fund, selling the investment star's fund for 60bps.
US drugs giant Pfizer has withdrawn its £55 a share, £69bn takeover bid for UK pharmaceutical firm AstraZeneca.
Lloyds Banking Group has announced plans to float a 25% stake in its TSB business next month in a bid to meet European rules on state aid for banks.